|
Sep 30
|
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
|
|
May 23
|
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
|
|
May 20
|
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
|
|
Apr 24
|
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
|
|
Jan 11
|
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
|
|
Dec 7
|
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
|
|
Nov 30
|
Helius Medical Technologies to Present at NobleCon19 Annual Conference
|
|
Nov 13
|
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript
|
|
Nov 6
|
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
|
|
Nov 2
|
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024
|
|
Aug 13
|
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q2 2023 Earnings Call Transcript
|
|
Aug 11
|
Q2 2023 Helius Medical Technologies Inc Earnings Call
|
|
Aug 10
|
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 10
|
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results
|